Endorphins and opiate antagonists in psychiatric research : clinical implications
著者
書誌事項
Endorphins and opiate antagonists in psychiatric research : clinical implications
Plenum Medical Book, c1982
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographies and index
内容説明・目次
内容説明
The discovery of new molecules that function in neuronal communication can be viewed as a progression of steps beginning with the identification of the molecular structure, moving to the understanding of the mecha- nisms mediating the synaptic action, and to the appraisal of the involve- ment of the new molecules in various neuronal mechanisms, and finally reaching the evaluation of this molecule's role in brain function and the consequences that are triggered by its abnormalities. Enkephalins have followed such a pattern, and the present publication expresses the salient points of the last two phases in this succession. Enkephalins were discovered in December 1975; in addition to pain threshold regulation, their participation in other brain functions was soon ascertained. Perhaps, there are multiple recognition sites for multiple molecular forms of endogenous enkephalins; similarly to other transmitter recognition sites, these are coupled with ionic and nucleotide amplifying systems; thus, when activated, they can modify membrane funtion and ionic permeability of membranes.
The present publication probes the current status of our knowledge concerning the consequences related to abnormalities in enkephalin storage, release, and synthesis. However, since our basic understanding of enkephalins is incomplete, the views reported should be considered to be in a state of flux.
目次
- Current Status of Endorphins and Opiate Antagonists in Psychiatry: An Overview.- 1 The Opiate Receptor and its Endogenous Ligands: An Overview.- 2 The Endorphins and Analgesia: A Minireview.- 3 Central Nervous System Effects after Systemic Injection of Opiate Peptides.- 4 Possible Roles of Prostaglandins in Mediating Opioid Actions.- 5 Psychoactive Agents and Enkephalin Degradation.- 6 Relationship of Opiate Peptides to Neuroendocrine Functions.- 7 ?-Endorphin and Central Nervous System.- 8 Biochemical Evidence for a Role for Endorphins in Mental Illness.- 9 Opiate Receptors and Opiate Antagonists in Psychiatric and Related Research: A Review.- 10 Endorphins in Psychiatric Research and Treatment.- 11 ?-Endorphin-Like Immunoreactivity in CSF and Plasma of Neuropsychiatric Patients.- 12 Cerebrospinal Fluid Content of Endorphins in Schizophrenia.- 13 Behavioral Effects of ?-Endorphin in Depression and Schizophrenia.- 14 Effects of Opiate Antagonists and Agonists on Behavioral and Neuoroendocrine Variables.- 15 The Narcotic Antagonists: Implications for Psychiatric Research.- 16 The Use of an Oral Opiate Antagonist in Schizophrenia.- 17 Peptides and Amino Acids in Human Hemodialysate.- 18 Dialysis of Schizophrenia.- 19 Hemodialyses and Schizophrenia: Effects of Hemodialyses on Schizophrenic Symptoms and Dialysate Endorphin Levels.- 20 Endorphin Dysfunction in Panic Anxiety and Primary Affective Illness.- 21 Endorphins and Affective Illness.- 22 Enkephalin, Naloxone, and [DES-TYR1]-?-Endorphin in Tardive Dyskinesia.- 23 The Importance of the Endorphin Systems in Chronic Pain Patients.- 24 Endorphins and ACTH: Normal Values
- Circadian Rhythms.- 25 ?-Endorphin in Human Plasma, Cerebrospinal Fluid, Pituitary, and ACTH-Producing Tumor.- 26 A Role for Opioid Peptides in Attentional Functioning: Clinical Implications.- 27 Future Scope for Endorphin Research.
「Nielsen BookData」 より